WO2011000698A2 - Soin capillaire monophasique à teneur accrue en silicone - Google Patents

Soin capillaire monophasique à teneur accrue en silicone Download PDF

Info

Publication number
WO2011000698A2
WO2011000698A2 PCT/EP2010/058442 EP2010058442W WO2011000698A2 WO 2011000698 A2 WO2011000698 A2 WO 2011000698A2 EP 2010058442 W EP2010058442 W EP 2010058442W WO 2011000698 A2 WO2011000698 A2 WO 2011000698A2
Authority
WO
WIPO (PCT)
Prior art keywords
preferred
group
alkyl
hair
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2010/058442
Other languages
German (de)
English (en)
Other versions
WO2011000698A3 (fr
Inventor
Jens Delowsky
Volker Scheunemann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of WO2011000698A2 publication Critical patent/WO2011000698A2/fr
Publication of WO2011000698A3 publication Critical patent/WO2011000698A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/88—Polyamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/896—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate
    • A61K8/898—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate containing nitrogen, e.g. amodimethicone, trimethyl silyl amodimethicone or dimethicone propyl PG-betaine

Definitions

  • the invention relates to single-phase hair treatment compositions comprising a cationic copolymer and an increased content of silicones and to the use of these hair-treatment compositions. Not least due to the heavy use of hair, for example by dyeing or perming, as well as by the cleaning of the hair with shampoos and by environmental pollution, the importance of care products with the longest possible effect increases.
  • composition according to the invention is outstandingly suitable for spray application as a non-aerosol.
  • an extremely uniform spray pattern is achieved compared to the usual two-phase products.
  • the entire composition is distributed very evenly on the hair.
  • a first object of the present invention is therefore a composition for
  • a cosmetic carrier a cosmetic carrier.
  • Ingredients a), b) and c) are described in detail below. As far as below the active ingredient complex (A) is spoken, this statement refers to the ingredients contained in the inventive compositions a), b) and c).
  • Hair treatment agents in the context of the present invention are, for example
  • Hair conditioners hair sprays, hair conditioners, hair treatments, hair wraps, hair tonics,
  • Hair fixatives hair dressings, hair styling preparations, hair lotions lotions, mousses,
  • Hair gels, hair waxes or combinations thereof are hair gels, hair waxes or combinations thereof.
  • Preferred agents according to the invention are hair gels, hair waxes or combinations thereof.
  • combing is understood according to the invention both the combability of the wet fiber, as well as the combability of the dry fiber.
  • combing work or the force used during the combing serves a
  • the measurement parameters can be judged by the expert or sensory
  • Measuring devices are quantified.
  • Shaping is understood to mean the ability to give a shape change to a group of previously treated keratin-containing fibers, in particular human hair. Hair cosmetics also speak of hair styling.
  • O / W, W / O and W / O / W are particularly suitable as cosmetic carriers c).
  • Emulsions in the form of creams or gels or other preparations which are particularly suitable for use on the hair.
  • the cosmetic carriers may in particular be aqueous or aqueous-alcoholic.
  • An aqueous cosmetic carrier contains at least 50% by weight of water.
  • aqueous-alcoholic cosmetic carriers include aqueous solutions containing from 3 to 70% by weight of a C 1 -C 6 -alcohol, in particular methanol,
  • Ethanol or propanol isopropanol, butanol, isobutanol, tert-butanol, n-pentanol, iso-pentanols, n-hexanol, isohexanols, glycol, glycerol, 1, 2-pentanediol, 1, 5-pentanediol, 1, 2-hexanediol or
  • agents according to the invention may additionally contain further organic radicals, 1, 6-hexanediol to understand.
  • the agents according to the invention may additionally contain further organic radicals
  • Solvents such as, for example, methoxybutanol, benzyl alcohol, ethyl diglycol or 1, 2
  • Propylene glycol included. Preference is given to all water-soluble organic solvents.
  • the agents according to the invention contain at least one cationic copolymer.
  • the cationic copolymer is in this case composed of the monomers of the formulas (1) and (2),
  • R1 to R9 independently of one another are hydrogen, C1-C4-alkyl, methyl, ethyl, propyl, isopropyl, butyl, isobutyl or tert-butyl and with the proviso that at least one of the radicals R6, R7, R8 or R9 C1-C4alkyl, n is an integer from 1 to 8 and A is a physiologically acceptable anion such as halide, fluoride, chloride, bromide, iodide, hydrogen sulfate or methosulfate.
  • R 1 is hydrogen or a methyl group, more preferably R 1 is a methyl group.
  • R2 is hydrogen or a C1-C4alkyl distr, more preferably R2 is hydrogen.
  • R3, R4 and R5 are independently hydrogen or a C1-C4alkyl distr, in particular a methyl group. More preferably, R3, R4 and R5 are the same and most preferably methyl.
  • the number n is preferably integer from 1 to 7, more preferably from 1 to 5, most preferably 1, 2, 3 or 4 and most preferably 2.
  • R6 is preferably hydrogen or methyl.
  • R 7 is preferably hydrogen, methyl or ethyl, more preferably methyl.
  • R 8 and R 9 are preferably identical and represent hydrogen, methyl or C 1 -C 4 -alkyl, particularly preferably hydrogen or methyl.
  • the monomer of formula (2) is dimethylacrylamide.
  • the copolymer according to the invention consists of 20 to 95% by weight of the monomer (1) and 5 to 50% by weight of the monomer (2).
  • the cationic copolymer of the invention may be further crosslinked.
  • the crosslinking by the usual cross-linking agent such as allyl acrylamide, allyl methacrylamide, tetraallylammonium chloride or N, N 'causes up to 500 ppm methylene bis-acrylamide in amounts.
  • the cationic copolymer as a solution or suspension or dispersion in suitable cosmetic media, such as propylene glycol, glycerol, paraffin, isoparaffin, propylene glycols and esters of propylene glycol such as propylene glycol dicaprylates / dicaprate, or PPG-1 trideceth-6 and others may be present.
  • suitable cosmetic media such as propylene glycol, glycerol, paraffin, isoparaffin, propylene glycols and esters of propylene glycol such as propylene glycol dicaprylates / dicaprate, or PPG-1 trideceth-6 and others
  • suitable cosmetic media such as propylene glycol, glycerol, paraffin, isoparaffin, propylene glycols and esters of propylene glycol such as propylene glycol dicaprylates / dicaprate, or PPG-1 trideceth-6 and others
  • the cationic copolymer such as a solution or suspension or dispersion in
  • the cationic copolymer of the present invention is used in an amount of 0.1 to 10% by weight based on the entire composition. Preference is given to amounts of from 0.1 to 5% by weight, more preferably from 0.1 to 3.0% by weight.
  • Ingredient b) of the compositions according to the invention is at least one silicone oil.
  • the selection of the silicone oil is carried out from the silicone oils known in the art.
  • the silicone oil is usually selected from the group of dimethicones, to which the cyclomethicones are also to be expected, and / or the group of amino-functional silicones and / or the group of dimethiconols.
  • dimethicone copolyols are to be expected among the silicone oils, it is preferred according to the invention to select no dimethicone copolyol.
  • the dimethicones according to the invention can be both linear and branched as well as cyclic or cyclic and branched.
  • Linear dimethicones can be represented by the following structural formula (Sil):
  • Branched dimethicones can be represented by the structural formula (SiH):
  • the radicals R 1 and R 2 are each independently hydrogen, a methyl radical, a C 2 to C 30 linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical.
  • the groups represented by R 1 and R 2 include alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, neopentyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-
  • R 1 examples include methylene, ethylene, propylene, hexamethylene, decamethylene, -CH 2 CH (CH 3 ) CH 2 -, phenylene, naphthylene, -CH 2 CH 2 SCH 2 CH 2 -, -CH 2 CH 2 OCH 2 - , -OCH 2 CH 2 -, -OCH 2 CH 2 CH 2 -, -CH 2 CH (CH 3 ) C (O) OCH 2 -, - (CH 2 ) 3 CC (O) OCH 2 CH 2 -, C 6 H 4 C 6 H 4 -, -C 6 H 4 CH 2 C 6 H 4 -; and - (CH 2 ) 3 C (O) SCH 2 CH 2 -.
  • R 1 and R 2 are methyl, phenyl and C 2 to C 22 alkyl radicals. Of the C2 to C22 alkyl radicals, lauryl, stearyl and behenyl radicals are particularly preferred.
  • the numbers x, y and z are integers and each run independently from 0 to 50,000.
  • the molecular weights of Dimethicone lie between 1,000 D and 10000000 D.
  • the viscosities are between 100 and 10,000,000 cPs measured at 25 0 C by means of a glass capillary viscometer according to Dow Corning Corporate Test Method CTM 0004 dated 20 July 1970. Preferred viscosities are 1000-5000000 cPs, most preferred viscosities are between 10,000 and 3,000,000 cps.
  • the most preferred range is between 50,000 and 2,000,000 cps. Most preferred are viscosities around the range of about 60,000 cps.
  • the word "about” defines a deviation from the stated value following the word “about” which is customary in the art for technically manufactured products. By way of example, reference may be made here to the product "Dow Corning 200 with 6000 OcSt” or “Dow Corning 200 with 5 cSt”.
  • cyclic dimethicones designated as cyclomethicones according to INCI are also preferably used according to the invention.
  • cosmetic or dermatological preparations according to the invention are preferred which contain at least one silicone of the formula (Si-4)
  • x is a number from 3 to 200, preferably from 3 to 10, more preferably from 3 to 7 and in particular 3, 4, 5 or 6 stands.
  • the dimethicones are present in the compositions according to the invention in amounts of from 0.1 to 25% by weight, preferably 0.1 to 20% by weight, particularly preferably 0.1 to 15.0% by weight and in particular 5.0 to 15.0 % By weight, based on the total composition.
  • Dimethiconols form another group of silicones which are particularly preferred according to the invention.
  • the dimethiconols according to the invention can be both linear and branched as well as cyclic or cyclic and branched.
  • Linear dimethiconols can be represented by the following structural formula (Si8-I):
  • Branched dimethiconols can be represented by the structural formula (Si8 - II)
  • the radicals R 1 and R 2 are each independently hydrogen, a methyl radical, a C 2 to C 30 linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical.
  • the groups represented by R 1 and R 2 include alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, neopentyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-
  • R 1 examples include methylene, ethylene, propylene, hexamethylene, decamethylene, -CH 2 CH (CH 3 ) CH 2 -, phenylene, naphthylene, -CH 2 CH 2 SCH 2 CH 2 -, -CH 2 CH 2 OCH 2 - , -OCH 2 CH 2 -, -OCH 2 CH 2 CH 2 -, -CH 2 CH (CH 3 ) C (O) OCH 2 -, - (CHz) 3 CC (O) OCH 2 CH 2 -, -C 6 H 4 C 6 H 4 -, -C 6 H 4 CH 2 C 6 H 4 -; and - (CH 2 ) 3 C (O) SCH 2 CH 2 -.
  • R 1 and R 2 are methyl, phenyl and C 2 to C 22 alkyl radicals.
  • the C2 to C22 alkyl radicals are especially lauryl, stearyl and behenyl radicals prefers.
  • the numbers x, y and z are integers and each run independently from 0 to 50,000.
  • the molecular weights of the dimethiconols are between 1,000 D and 10000000 D.
  • the viscosities are between 100 and 10,000,000 cPs measured at 25 0 C by means of a glass capillary viscometer according to Dow Corning Corporate Test Method CTM 0004 dated 20 July 1970.
  • Preferred viscosities are from 1000 to 5,000,000 cPs, most preferred viscosities are between 10,000 and 3,000,000 cps. The most preferred range is between 50,000 and 2,000,000 cps.
  • Examples of such products include the following commercial products: Botanisil NU-150M (Botanigenics), Dow Coming 1-1254 Fluid, Dow Corning 2-9023 Fluid, Dow Corning 2-9026 Fluid, Ultrapure Dimethiconol (Ultra Chemical), Unisil SF- R (Universal Preserve), X-21-5619 (Shin-Etsu Chemical Co.), Abil OSW 5 (Degussa Care Specialties), ACC DL-9430 Emulsion (Taylor Chemical Company), AEC Dimethiconol & Sodium Dodecylbenzenesulfonate (A & E Connock (Perfumery & Cosmetics) Ltd.), BC Dimethiconol Emulsion 95 (Basildon Chemical Company, Ltd.), Cosmetic Fluid 1401, Cosmetic Fluid 1403, Cosmetic Fluid 1501, Cosmetic Fluid 1401 DC (all aforementioned Chemsil Silicones, Inc.), Dow Corning 1401 Fluid, Dow Corning 1403 Fluid, Dow Corning 1501 Fluid, Dow Corning 1784 HVF
  • the dimethiconols (Si8) are present in the compositions according to the invention in amounts of from 0.1 to 20% by weight, preferably 0.1 to 15% by weight, more preferably 0.1 to 10.0% by weight and in particular 0.1 to 7.5% by weight of dimethiconol based on the total composition.
  • Particularly preferred agents according to the invention contain one or more amino-functional silicones. Such silicones may e.g. by the formula (Si-2)
  • R is a hydrocarbon or a hydrocarbon radical having from 1 to about 6
  • Q is a polar radical of the general formula -R 1 HZ
  • R 1 is a divalent linking group bonded to hydrogen and the radical Z, composed of carbon and hydrogen atoms, Carbon, hydrogen and oxygen atoms or carbon, hydrogen and nitrogen atoms, and
  • Z is an organic, amino-functional group containing at least one amino-functional group
  • b takes values in the range of about 1 to about 3,
  • a + b is less than or equal to 3
  • c is a number in the range of about 1 to about 3, and
  • x is a number ranging from 1 to about 2,000, preferably from about 3 to about 50, and most preferably from about 3 to about 25, and
  • y is a number in the range of from about 20 to about 10,000, preferably from about 125 to about 10,000, and most preferably from about 150 to about 1,000, and M is a suitable silicone end group as known in the art, preferably trimethylsiloxy ,
  • Non-limiting examples of the groups represented by R in formula (Si-2) include alkyl groups such as methyl, ethyl, propyl, isopropyl, isopropyl, butyl, isobutyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-bromobutyl, 3,3,3-trifluoropropyl, chlorocyclohexyl, bromophenyl, chlorophenyl and the like, and sulfur-containing radicals such as mercaptoethyl, mer
  • R 1 examples include methylene, ethylene, propylene, hexamethylene, decamethylene, - CH 2 CH (CH 3 ) CH 2 -, phenylene, naphthylene, -CH 2 CH 2 SCH 2 CH 2 -, -CH 2 CH 2 OCH 2 - , -OCH 2 CH 2 -, - OCH 2 CH 2 CH 2 -, -CH 2 CH (CH 3 ) C (O) OCH 2 -, - (CHz) 3 CC (O) OCH 2 CH 2 -, -C 6 H 4 C 6 H 4 -, -C 6 H 4 CH 2 C 6 H 4 -; and - (CH 2 ) 3 C (O) SCH 2 CH 2 -.
  • Z is according to formula (Si-2) an organic, amino-functional radical containing at least one functional amino group.
  • a possible formula for said Z is NH (CH 2 ) Z NH 2 , where z is an integer greater than or equal to 1.
  • Another possible formula for said Z is -NH (CH 2 ) Z (CH 2 ) zz NH, wherein both z and zz independently of one another are an integer greater than or equal to 1, this structure comprising diamino ring structures, such as piperazinyl.
  • Said Z is most preferably an -NHCH 2 CH 2 NH 2 radical.
  • Z is - N (CH 2 ) Z (CH 2 ) ZZ NX 2 or -NX 2 , wherein each X of X 2 is independently selected from the group consisting of hydrogen and alkyl groups of 1 to 12 carbon atoms, and zz is 0.
  • Q according to formula (Si-2) is most preferably a polar amino-functional radical of formula - CH 2 CH 2 CH 2 NH 2 CH 2 CH 2 NH 2 .
  • ⁇ assumes values in the range of 0 to 2
  • b takes values in the range of 2 to 3
  • a + b is less than or equal to 3
  • c is a number in the range of 1 to 3.
  • the molar ratio of the R a Q b SiO (4 a a b) / 2 units to the R 0 SiO (4 C) / 2 units in formula (Si-2) is in the range of about 1: From 2 to 1:65, preferably from about 1: 5 to about 1:65, and most preferably from about 1: 15 to about 1: 20. If one or more of the above silicones are used Formula (Si-2), then the various variable substituents in the above formula may be different for the various silicone components present in the silicone blend.
  • Preferred cosmetic or dermatological preparations according to the invention contain an amino-functional silicone of the formula (Si-3)
  • G is -H, a phenyl group, -OH, -O-CH 3 , -CH 3 , -O-CH 2 CH 3 , -CH 2 CH 3 , -O-CH 2 CH 2 CH 3 , -CH 2 CH 2 CH 3 , -O-CH (CH 3 ) 2 , -CH (CH 3 ) 2 , -O-CH 2 CH 2 CH 2 CH 3 , -CH 2 CH 2 CH 2 CH 3 , -O-CH 2 CH ( CH 3 ) 2 , -CH 2 CH (CH 3 ) 2 , -O-CH (CH 3 ) CH 2 CH 3 , -CH (CH 3 ) CH 2 CH 3 , -CH (CH 3 ) CH 2 CH 3 , -O-C (CH 3 ) 3 , - C (CH 3 ) 3 ;
  • a is a number between 0 and 3, in particular 0;
  • b stands for a number between 0 and 1, in particular 1,
  • n and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n is preferably values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10,
  • R ' is a monovalent radical selected from
  • each Q is a chemical bond, -CH 2 -, -CH 2 -CH 2 -, -CH 2 CH 2 CH 2 -, -C (CH 2 ) 2 -, -CH 2 CH 2 CH 2 CH 2 -, - CH 2 C (CH 3 ) 2 -, -CH (CH 2 ) 2 CH 2 -,
  • R " is identical or different radicals from the group -H, -phenyl, -benzyl, -CH 2 -CH (CH 3 ) Ph, the Ci. 20 -alkyl radicals, preferably -CH 3 , -CH 2 CH 3 , -CH 2 CH 2 CH 3 , -CH (CH 3 ) 2 , -CH 2 CH 2 CH 2 CH 3 , -CH 2 CH (CH 3 ) 2 , -CH (CH 3 ) CH 2 CH 3 , -C (CH 3 J 3 , and A represents an anion, which is preferably selected from chloride, bromide, iodide or methosulfate.
  • Cationic silicone oils such as the commercially available Dow Corning 929 emulsion (containing a hydroxylamino-modified silicone referred to as amodimethicone), Dow Corning 939, Dow Corning 949, Dow Corning 959, DC 2-2078 (manufactured by Dow Corning , INCI name: Aminopropyl Phenyl Trimethicone), DC 5-7113 (manufacturer Dow Corning, INCI name: Silicone Quaternium 16), SM-2059 (manufacturer: General Electric) and SLM-55067 (manufacturer: Wacker).
  • Particularly preferred agents according to the invention are characterized in that they contain at least one amino-functional silicone of the formula (Si 3-a)
  • n and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n preferably values of 0 to 1999 and in particular of 49 to 149 and m preferably values of 1 to 2000 , in particular from 1 to 10 assumes.
  • silicones are referred to as trimethylsilylamodimethicones according to the INCI declaration and are available, for example, under the name Q2-7224 (manufacturer: Dow Corning, a stabilized trimethylsilylamodimethicone).
  • compositions according to the invention which contain at least one amino-functional silicone of the formula (Si-3b)
  • R is -OH, an (optionally ethoxylated and / or propoxylated) (Ci to C 2 o) -
  • R ' is -OH, a (C 1 to C 2 o) alkoxy group or a -CH 3 group and
  • n1 and n2 are numbers whose sum (m + n1 + n2) is between 1 and 2000, preferably between 50 and 150, the sum (n1 + n2) preferably having values from 0 to 1999 and in particular from 49 to 149 and m preferably assumes values of from 1 to 2000, in particular from 1 to 10.
  • silicones are according to the INCI declaration as Amodimethicone, or as functionalized Amodimethicone, such as bis (C13-15 alkoxy) PG Amodimethicone (for example, as a commercial product: DC 8500 from Dow Corning available), trideceth-9 PG-amodimethicones (for example as a commercial product Silcare Silicone SEA available from Clariant). Regardless of which amino-functional silicones are used, are
  • Cosmetic preparations according to the invention which contain an amino-functional silicone whose amine number is above 0.25 meq / g, preferably above 0.3 meq / g and in particular above 0.4 meq / g.
  • the amine number stands for the milliequivalents of amine per gram of the amino-functional silicone. It can be determined by titration and also expressed in mg KOH / g.
  • amino-functional silicones can be used which are characterized by terminal amino groups, which in turn are particularly preferably quaternary. Excellent are here diquaternary silicones. Suitable diquaternary silicones are selected from compounds of the general formula (Si3c)
  • radicals R 7 to R 12 independently of one another, are identical or different and denote C 1 to C 10 -alkyl or phenyl,
  • A represents a divalent organic linking group
  • n is a number from 0 to 200, preferably from 10 to 120, particularly preferably from 10 to 40, and
  • the divalent linking group is preferably a C1 to C12 alkylene or
  • Alkoxyalkylene group which may be substituted with one or more hydroxyl groups.
  • the anion X " can be a halide ion, an acetate, an organic carboxylate or a
  • a preferred diquaternary silicone has the general formula (Si3d)
  • A is the group - (CH 2 ) 3 - O - CH 2 - CH (OH) - CH 2 -,
  • R is an alkyl radical having at least 8 C atoms and n is a number from 10 to 120.
  • Suitable silicone polymers having two terminal quaternary ammonium groups are known under the INCI name Quaternium-80. These are dimethylsiloxanes with two terminal trialkylammonium groups. Such diquaternary polydimethylsiloxanes are marketed by Evonik under the trade names Abil ® Quat 3270, 3272 and 3474th
  • amino-functional silicones are known in which the siloxane substructures are optionally connected to each other via ammonium substructures.
  • These polyammonium polysiloxane compounds may be obtained for example under the trade name Baysilone® ® GE Bayer Silicones.
  • Baysilone TP 3911, SME 253 and SFE 839 are preferred.
  • Very particular preference is given to the use of Baysilone TP 391 1 as the active component of the compositions according to the invention.
  • Cosmetic or dermatological preparations preferred according to the invention are characterized in that, based on their weight, they contain 0.1 to 15% by weight, preferably 0.1 to 10% by weight, particularly preferably 0.1 to 7.5% by weight and in particular from 0.1 to 5% by weight of amino-functional silicone (s) and / or diquaternary silicone.
  • silicones can be present in the compositions according to the invention.
  • dimethicone copolyols according to the invention are, for example, those sold commercially under the trade names SILWET (Union Carbide Corporation) and DOW
  • dimethicone copolyols according to the invention are Dow Corning 190 and Dow
  • the Dimethiconcopolyole are in the compositions of the invention in amounts of
  • 0.01 to 10 wt.% Preferably 0.01 to 8 wt.%, Particularly preferably 0.1 to 7.5 wt.% And in particular 0.1 to 5 wt.% Of dimethicone copolyol based on the composition.
  • Ingredients b) from the different classes mentioned at least two different classes can be used in the compositions according to the invention.
  • the use of a mixture of silicone oils is preferred.
  • This mixture of silicone oils preferably contains at least one dimethicone, which in turn also the
  • Cyclomethicones are to be expected.
  • the dimethicones are particularly preferably selected from at least two different viscosity ranges.
  • Viscosity can be used between 10,000 and 100,000 cps. It is most preferred if at least one cyclomethicone is further used with these two dimethicones.
  • a ratio of 20: 1 to 5: 1 is particularly preferred.
  • the total amount of all silicone oils preferred according to the invention is at least 5.0 to 30.0
  • Preferred embodiments of the invention comprise, in addition to a cosmetic carrier c) and the cationic copolymer a), the following ingredients b) as compulsory ingredients:
  • Embodiment 1 is a diagrammatic representation of Embodiment 1:
  • Embodiment 2 is a diagrammatic representation of Embodiment 1:
  • Embodiment 1 at least 0.1 to 10.0 wt.% Of an amino-functional silicone is further contained.
  • the total amount of silicone in the composition remains unchanged at at least 5.0 to at most 30.0 wt% in relation to the whole Composition.
  • the abovementioned preferred ranges for the amino-functional silicone also apply, and in particular in this embodiment.
  • Embodiment 3 is a diagrammatic representation of Embodiment 3
  • the low-viscosity dimethicone is partially a cyclomethicone.
  • the low-viscosity dimethicone and the cyclomethicone are in a ratio of 2: 1 to 1: 2, preferably 1: 1.
  • the further features of embodiment 1 apply here unchanged and are applied to the mixture of low-viscosity dimethicone and cyclomethicone.
  • Embodiment 4 is a diagrammatic representation of Embodiment 4:
  • Embodiment 4 substantially corresponds to Embodiment 2. Unlike Embodiment 2, as the low-viscosity dimethicone, a low-viscosity dimethicone and a cyclomethicone according to the provisos of Embodiment 3 are used.
  • the present active ingredient combination according to the invention can be formulated as a rinse-off application or as a leave-on application.
  • An application as a leave-on application is preferred.
  • packaging as a non-aerosol spray is particularly preferred.
  • cosmetic oils can be used. These oil bodies preferably have a melting point of less than 50 ° C., more preferably less than 45 ° C., very preferably less than 40 ° C., most preferably less than 35 ° C., and most preferably the cosmetic oils are at a temperature of less than 30 ° C flowable. In the following, these oils are defined and described in more detail.
  • the natural and synthetic cosmetic oils include, for example:
  • oils examples include sunflower oil, olive oil, soybean oil, rapeseed oil, almond oil, jojoba oil, orange oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil. Also suitable, however, are other triglyceride oils such as the liquid portions of beef tallow as well as synthetic triglyceride oils.
  • the compounds are available as commercial products 1, 3-di- (2-ethyl-hexyl) - cyclohexane (Cetiol ® S), and di-n-octyl ether (Cetiol ® OE) may be preferred.
  • Ester oils are to be understood as meaning the esters of C 6 - C 30 fatty acids with C 2 - C 30 fatty alcohols.
  • the monoesters of the fatty acids with alcohols having 2 to 24 carbon atoms are preferred.
  • fatty acid components used in the esters are caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitoleic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linolenic Behenic acid and erucic acid and their technical mixtures. Examples of the
  • Fatty alcohol components in the ester oils are isopropyl alcohol, caproic alcohol, capryl alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol,
  • isopropyl myristate IPM Rilanit ®
  • isononanoic acid C16-18 alkyl ester Cetiol ® SN
  • 2-ethylhexyl palmitate Cegesoft ® 24
  • Stearic acid-2-ethylhexyl ester (Cetiol ® 868), cetyl oleate, glycerol tricaprylate, caprate Kokosfettalkohol- / caprylate (Cetiol ® LC), n-butyl stearate, oleyl erucate (Cetiol ® J 600), isopropyl palmitate (IPP Rilanit ®), Oleyl Oleate (Cetiol ®), hexyl laurate (Cetiol ® A), di-n-butyl adipate (Cetiol ® B), myristyl myristate (Cetiol ® MM), Cetearyl Isononanoate (Cetiol ® SN),
  • Dicarboxylic acid esters such as di-n-butyl adipate, di- (2-ethylhexyl) adipate, di- (2-ethylhexyl) succinate and di-isotridecyl acelate
  • diol esters such as ethylene glycol dioleate, ethylene glycol diisotridecanoate, propylene glycol di (2- ethylhexanoate), propylene glycol diisostearate,
  • Fatty acid partial glycerides which are monoglycerides, diglycerides and their technical
  • the partial glycerides preferably follow the formula (D4-I),
  • R 3 in the R 1 , R 2 and R 3 is independently of one another hydrogen or a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22, preferably 12 to 18, Carbon atoms are provided with the proviso that at least one of these groups is an acyl radical and at least one of these groups is hydrogen.
  • the sum (m + n + q) is 0 or numbers from 1 to 100, preferably 0 or 5 to 25.
  • R 1 is an acyl radical and R 2 and R 3 are hydrogen and the sum (m + n + q) is 0.
  • Typical examples are mono- and / or diglycerides based on caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linolenic , Elaeo- Stearic acid, arachidic acid, gadoleic acid, behenic acid and erucic acid and their technical mixtures.
  • oleic acid monoglycerides are used.
  • Natural oils include, for example, amaranth seed oil, apricot kernel oil, argan oil, avocado oil, babassu oil, cottonseed oil, borage seed oil, camelina oil, safflower oil, peanut oil, pomegranate seed oil, grapefruit seed oil, hemp oil, hazelnut oil, elderflower seed oil, currant seed oil, jojoba oil, cocoa butter, linseed oil, macadamia nut oil, corn oil, almond oil, marula oil , Evening primrose oil, olive oil, palm oil, rapeseed oil, rice oil, sea buckthorn fruit oil, sea buckthorn seed oil, sesame oil, shea butter, soybean oil, sunflower oil, grapeseed oil, walnut oil or wild rose oil.
  • the agents contain at least one surface-active substance, whereby in principle both anionic and zwitterionic, ampholytic, nonionic and cationic surface-active substances are suitable.
  • the choice of surfactants depends on the nature of the agent.
  • at least one surfactant is selected from the group of anionic, zwitterionic or nonionic surface-active substances. It is preferred here that at least one anionic and at least one zwitterionic surface-active substance is chosen.
  • These surface-active substances are particularly preferably selected from the group of particularly mild surface-active substances. In many cases, however, it has proved to be advantageous to select the surfactants from anionic, zwitterionic or nonionic surfactants.
  • anionic and zwitterionic surface-active substances are between 10: 1 and 1: 5.
  • the ratio is particularly preferably 5: 1 to 1: 2.
  • Suitable anionic surfactants (tanion) in preparations according to the invention are all suitable for use on the human body suitable anionic surfactants.
  • the following anionic surfactants have proven to be mild to particularly mild and are particularly preferred according to the invention:
  • Ethercarbon Acid the formula RO- (CH 2 -CH 2 O) x -CH 2 -COOH, in which R is a linear
  • Alkyl group having 8 to 30 carbon atoms and x 0 or 1 to 16 and their salts,
  • Sulfosuccinic acid mono-alkyl polyoxyethyl esters having 8 to 24 C atoms in the alkyl group and 1 to 6 oxyethyl groups.
  • Alkylpolyglykolethersulfate of the formula RO (CH 2 -CH 2 O) x -OSO 3 H, in which R is a preferably linear alkyl group having 8 to 30 carbon atoms and x 0 or 1 to 12,
  • R 1 is preferably an aliphatic hydrocarbon radical having 8 to 30 carbon atoms
  • R 2 is hydrogen, a radical (CH 2 CH 2 O) n R 2 or X, n is from 1 to 10 and X is hydrogen, an alkali metal radical or alkaline earth metal or NR 3 R 4 R 5 R 6 , where R 3 to R 6 independently of one another represent hydrogen or a C 1 to C 4 hydrocarbon radical,
  • RCO is a linear or branched acyl radical having 6 to 22 carbon atoms
  • x, y and z are in total 0 or numbers of 1 to 30, preferably 2 to 10
  • X is an alkali or alkaline earth metal.
  • monoglyceride (ether) sulfates suitable for the purposes of the invention are the reaction products of lauric acid monoglyceride, coconut fatty acid monoglyceride, palmitic acid monoglyceride, stearic acid monoglyceride, oleic acid monoglyceride and tallow fatty acid monoglyceride and also their ethylene oxide adducts
  • Sulfur trioxide or chlorosulfonic acid in the form of its sodium salts.
  • monoglyceride sulfates are used in which RCO is a linear acyl radical having 8 to 18 carbon atoms,
  • n is an integer from 1 to 20 and R 2 is hydrogen, a methyl, ethyl, propyl, isopropyl, n-butyl, t-butyl or iso-butyl radical and M is hydrogen or a metal such as alkali metal, in particular sodium, potassium, lithium, alkaline earth metal, in particular magnesium, calcium, zinc, or an ammonium ion, such as + NR 3 R 4 R 5 R 6 , with R 3 to R 6 independently of one another represent hydrogen or a C 1 to C 4 hydrocarbon radical.
  • Such products are available, for example, by the company Chem Y under the product Akypo ®.
  • Protein hydrolysates with a suitable fatty acid derivative for example a C8 - C30 fatty acid halide.
  • a suitable fatty acid derivative for example a C8 - C30 fatty acid halide.
  • Such products are available under the trademark Lamepon® ®, Maypon ®, Gluadin® ®, Hostapon® ® KCG or Amisoft ® has long been in the trade,
  • the number of glycol ether groups is 1 to 20, preferably 2 to 15, more preferably 2 to 12.
  • Particularly mild anionic surfactants having polyglycol ether groups with no restricted homolog distribution can be obtained, for example on the one hand the number of polyglycol ether groups is 4 to 12 and Zn or Mg ions are selected as counterion.
  • Example is the commercial product Texapon.RTM ® ASV.
  • Zwitterionic surfactants are those surface-active compounds which in the molecule have at least one quaternary ammonium group and at least one -COO () - or -SO 3 ⁇ group wear.
  • Particularly suitable zwitterionic surfactants are the so-called betaines such as N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinates, for example cocoacylaminopropyl-dimethylammonium glycinate, and Alkyl-3-carboxymethyl-3-hydroxyethyl-imidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group and Kokosacylaminoethylhydroxyethylcarboxymethylglycinat.
  • a preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name Cocamidopropyl Betaine.
  • Ampholytic surfactants are understood as meaning those surface-active compounds which contain, in addition to a C 8 -C 24 -alkyl or -acyl group, at least one free amino group and at least one -COOH or -SO 3 H group in the molecule and for the formation of internal Salts are capable.
  • ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 24 C Atoms in the alkyl group.
  • amphoteric or zwitterionic surfactants are alkylbetaines, alkylamidobetaines, aminopropionates, aminoglycinates, imidazolinium betaines and sulfobetaines.
  • ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C 12 -C 18 -acylsarcosine.
  • Nonionic surfactants are for example
  • R 1 CO is a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22 carbon atoms
  • R 2 is hydrogen or methyl
  • R 3 is a linear or branched alkyl radical having 1 to 4 carbon atoms and w is a number from 1 to 20 stands,
  • R 4 is an alkyl or alkenyl radical having 4 to 22 carbon atoms
  • G is a
  • R 5 CO for an aliphatic acyl radical having 6 to 22 carbon atoms
  • R 6 for an aliphatic acyl radical having 6 to 22 carbon atoms
  • a most preferred embodiment contains at least one cationic surfactant.
  • Cationic surfactants are generally derived from ammonium ions and have a structure (NR 1 R 2 RV) + A " (Tkati)
  • the anion A is selected from the physiologically acceptable anions.
  • Illustrative of the anion are the halides, fluoride, chloride, bromide, iodide, phosphate, dihydrogen phosphate, hydrogen phosphate, hydrogen sulfate, sulfate (methosulfate) of the general formula RSO 3 " in which R has the meaning of saturated or unsaturated alkyl radicals having 1 to 4 carbon atoms, in particular methosulfate and ethosulfate, or anionic organic acid residues such as maleate, fumarate, oxalate, tartrate, citrate, lactate or acetate, particularly preferred cationic surfactants have as anion the chloride or methosulfate with a methyl or ethyl group as radical R.
  • Such cationic ammonium compounds of the formula (Tkati) are well known to the person skilled in the art.
  • the radicals R 1 to R 4 may each independently of one another denote straight-chain, branched, cyclic, aromatic saturated or unsaturated alkyl and / or alkenyl chains having at least 1 to 30 carbon atoms, hydrogen, -OH or hydroxyethyl.
  • R 1 represents a saturated, branched or unbranched alkyl radical having a chain length of 16 to 24 carbon atoms and furthermore the radical are preferred according to the invention
  • R4 represents a saturated, branched or unbranched alkyl radical, more preferably unbranched alkyl radical having a chain length of 18 to 24, most preferably having a chain length of 22 to 24 carbon atoms.
  • Preferred quaternary ammonium compounds of the structure are ammonium halides, especially chlorides and bromides, such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides, for example, distearyldimethylammonium chloride, Lauryldimethylammo- niumchlorid, lauryldimethylbenzylammonium chloride and tricetylmethyl ammonium chloride, cetyltrimethylammonium chloride, cetyltrimethylammonium bromide, cetyltrimethylammonium methosulfate, stearyl trimethyl ammonium chloride, behenyl trimethyl ammonium chloride, behenyl trimethyl ammonium bromide and behenyl trimethyl ammonium methosulfate , Preference is given to cetyltrimethylammonium and behenyltrimethylammonium salts.
  • chlorides and bromides such as al
  • cetyltrimethylammonium methosulfate and behenyltrimethylammonium methosulfate are particularly preferred.
  • cetyltrimethylammonium methosulfate and behenyltrimethylammonium methosulfate are particularly preferred.
  • behenyltrimethylammonium methosulfate is particularly preferred.
  • esterquats according to the formula (Tkat1-2) can be used.
  • radicals R1, R2 and R3 are each independently and may be the same or different.
  • the radicals R1, R2 and R3 mean:
  • a branched or unbranched alkyl radical having 1 to 4 carbon atoms which may contain at least one hydroxyl group, for example methyl, ethyl, propyl, isopropyl, butyl, isobutyl, t-butyl, hydroxyethyl, hydroxymethyl, or
  • aryl or alkaryl radical for example phenyl or benzyl
  • the remainder - (A - R4) is contained at least 1 to 3 times.
  • n 1 to 200, preferably 1 to 100, particularly preferably 1 to 50, and particularly preferably 1 to 20 with R 5 in the meaning of hydrogen, methyl or ethyl,
  • R4 stands for: 1) R6-0-C0-, wherein R6 is a saturated or unsaturated, branched or
  • cyclic saturated or unsaturated alkyl radical having 6 to 30 carbon atoms, which may contain at least one hydroxy group, and which may optionally be further ethoxylated with 1 to 100 ethylene oxide units and / or 1 to 100 propylene oxide units, or
  • R7-CO- wherein R7 is a saturated or unsaturated, branched or unbranched or cyclic saturated or unsaturated alkyl radical having 6 to 30
  • Carbon atoms which may contain at least one hydroxy group, and which may optionally be further ethoxylated with 1 to 100 ethylene oxide units and / or 1 to 100 propylene oxide units,
  • esterquats are quaternized ester salts of fatty acids with triethanolamine, quaternized ester salts of fatty acids with diethanolalkylamines and quaternized ester salts of fatty acids with 1,2-dihydroxypropyldialkylamines.
  • Such products are marketed under the trademarks Rewoquat ®, Stepantex® ®, ® and Dehyquart® Armocare® ®.
  • the products Armocare ® VGH- 70, a N, N-bis (2-palmitoyloxyethyl) dimethylammonium chloride, as well as Dehyquart ® F-75, Dehyquart ® C-4046, Dehyquart ® L80, Dehyquart ® F-30, Dehyquart ® AU 35, Rewoquat ® WE18, Rewoquat WE38 ® DPG and Stepantex ® GS 90 are examples of such esterquats.
  • R8 corresponds in its meaning R7.
  • cationic surfactants are cationic surfactants of the formula (Tkat-2).
  • R here stands for a substituted or unsubstituted, branched or straight-chain alkyl or alkenyl radical having 11 to 35 carbon atoms in the chain
  • X is - O - or - NR 5 -
  • R 1 represents an alkylene group having 2 to 6 C atoms, which may be unsubstituted or substituted, in which case substitution with an -OH or -NH group is preferred in the case of a substitution,
  • R 2 and R 3 each independently represent an alkyl or hydroxyalkyl group having 1 to 6 C atoms in the chain, which chain may be straight or branched.
  • radicals according to the invention are methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, pentyl, isopentyl, neopentyl, hexyl, iso-hexyl, hydroxyalkyl, dihydroxyalkyl, hydroxyethyl, Hydroxypropyl, dihydroxypropyl, hydroxybutyl, dihydroxybutyl, trihydroxybutyl, trihydroxypropyl, dihydroxyethyl,
  • R5 is hydrogen or a C1 to C6 straight-chain or branched, alkyl or alkenyl radical which may also be substituted by a hydroxyl group, especially methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, pentyl, iso-pentyl, neo-pentyl, hexyl, iso -hexyl, hydroxyethyl, hydroxypropyl, dihydroxypropyl, hydroxybutyl, dihydroxybutyl, trihydroxybutyl, trihydroxypropyl, dihydroxyethyl and
  • a ' denotes an anion as already described in the formula (Tkati).
  • compositions according to the invention furthermore comprise at least one amine and / or cationized amine, in particular an amidoamine and / or a cationized amidoamine having the following structural formulas:
  • R1 is an acyl or alkyl radical having 6 to 30 carbon atoms, which may be branched or unbranched, saturated or unsaturated, and wherein the acyl radical and / or the alkyl radical may contain at least one OH group, and
  • R 2, R 3 and R 4 are each independently of one another hydrogen or an alkyl radical having 1 to 4 C atoms, which may be identical or different, saturated or unsaturated, and
  • n is an integer between 1 and 10.
  • the anion is in turn selected from the physiologically acceptable anions as already described in the formula (Tkati).
  • R1 is a branched or unbranched, saturated or unsaturated acyl radical with 6 to 30 carbon atoms, which may contain at least one OH group means.
  • amidoamines and / or quaternized amidoamines in which R 2, R 3 and / or R 4 in formulas (Tkat7) and / or (Tkat ⁇ ) represent a radical according to the general formula CH 2 CH 2 OR 5, where R 5 is the meaning of alkyl radicals having 1 to 4 carbon atoms, hydroxyethyl or hydrogen.
  • R 5 is the meaning of alkyl radicals having 1 to 4 carbon atoms, hydroxyethyl or hydrogen.
  • the preferred size of n in the general formulas (Tkat7) and / or (Tkat ⁇ ) is an integer between 2 and 5.
  • the alkylamidoamines can both be present as such and converted by protonation in a correspondingly acidic solution into a quaternary compound in the composition. According to the invention, the cationic alkylamidoamines are preferred.
  • amidoamines to be used according to the invention are, for example, amidoamines: Witcamine 100 (Witco, INCI name: Cocamidopropyl Dimethylamine), Incromine BB (Croda, INCI name: behenamidopropyl dimethylamine), Mackin 401 (McIntyre, INCI name: isostearylamidopropyl dimethylamine) and other Mackine types, Adogen S18V (Witco, INCI name: Stearylamidopropyl Dimethylamine), and as permanent cationic aminoamines: Rewoquat RTM 50 (Witco Surfactants GmbH, INCI name: Ricinoleamidopropyltrimonium Methosulfate), Empigen CSC (Albright & Wilson, INCI name: Cocamidopropyltrimonium chloride), Swanol Lanoquat DES-50 (Nikko, INCI name: Quatemium-33), Rewoquat U
  • quaternary imidazoline compounds i. Compounds having a positively charged imidazoline ring can be used.
  • the formula (Tkat9) shown below shows the structure of these compounds.
  • radicals R independently of one another each represent a saturated or unsaturated, linear or branched hydrocarbon radical having a chain length of 8 to 30
  • the preferred compounds of formula (Tkat9) for R each contain the same hydrocarbon radical.
  • the radicals R are each independently a saturated or unsaturated, linear or branched hydrocarbon radical having a chain length of 8 to 18 carbon atoms.
  • the preferred compounds of the formula I each contain the same hydrocarbon radical for R.
  • the chain length of the radicals R is preferably 12 to 18 carbon atoms. Particularly preferred are compounds having a chain length of at least 16 carbon atoms and most preferably having 18 carbon atoms.
  • the chain length of the radicals R is most preferably at least 20 carbon atoms. Most preferred are compounds having a chain length of at least 21 carbon atoms.
  • Preferred radicals R are cetyl, oleyl, palmityl, stearyl and behenyl.
  • A is a physiologically acceptable anion, as already described for the cationic compounds of the formula (Tkati).
  • Especially examples of the invention are available under the INCII names Quaternium-27, Quaternium-72 and Quaternium-83.
  • a supreme preferred commercial product of this chain length is known for example under the name Quaternium-91.
  • the teaching of the invention also includes that at least two cationic surfactants are used.
  • the cationic surfactants are selected from two different structural classes.
  • the cationic surfactants are present in the compositions according to the invention in amounts of from 0.01 to 20% by weight, preferably in amounts of from 0.01 to 10% by weight and very particularly preferably in amounts of from 0.1 to 7.5% by weight , The very best results are obtained with amounts of from 0.1 to 5% by weight, based in each case on the total composition of the particular agent.
  • Cationic, zwitterionic and / or amphoteric surfactants and mixtures thereof may be preferred according to the invention.
  • the surfactants (T) are used in amounts of 0.05-45% by weight, preferably 0.1-30% by weight and very particularly preferably 0.5-25% by weight, based on the total agent used according to the invention ,
  • Emulsifiers which can be used according to the invention are, for example
  • Ethercarbon Acid the formula RO- (CH 2 -CH 2 O) x -CH 2 -COOH, in which R is a linear
  • Alkyl group having 8 to 30 C atoms and x 0 or 1 to 16,
  • Sulfosuccinic acid mono-alkyl polyoxyethyl esters having 8 to 24 C atoms in the alkyl group and 1 to 6 oxyethyl groups
  • Ampholytic surfactants (Tampho),
  • Polyol fatty acid esters such as the commercial product Hydagen ® HSP (Cognis) or
  • R 1 O [CH 2 CH (CH 3 ) O] X (CH 2 CHR 2 O) X [CH 2 CH (OH) R 3 I Z with R 1 being a linear or branched, saturated or unsaturated alkyl and / or or alkenyl radical having 2 to 30 C atoms, R 2 is hydrogen, a methyl, ethyl, propyl or iso - propyl radical, R 3 is a linear or branched alkyl radical having 2 to 30 C atoms, x is 0 or a number from 1 to 20, Y stands for a number from 1 to 30 and z stands for the number 1, 2, 3, 4 or 5.
  • Alkylamidoamines and quaternized alkylamidoamines are quaternized alkylamidoamines.
  • alkyl (oligo) glucosides for example, the commercially available product ® Montanov 68,
  • glucose phospholipids e.g. as lecithins or phosphatidylcholines from e.g. Egg yolk or plant seeds (e.g., soybeans) are understood.
  • Fatty acid esters of sugars and sugar alcohols such as sorbitol
  • Polyglycerols and polyglycerol derivatives such as polyglycerol poly-12-hydroxystearate (commercial product Dehymuls ® PGPH),
  • Very particularly cationic and / or amphoteric and / or zwitterionic polymers are used as further ingredients in the compositions according to the invention.
  • the cationic polymers may be homo- or copolymers, the quaternary
  • Nitrogen groups are contained either in the polymer chain or preferably as a substituent on one or more of the monomers.
  • the ammonium group-containing monomers may be copolymerized with non-cationic monomers.
  • Suitable cationic monomers are unsaturated, free-radically polymerizable compounds which carry at least one cationic group, in particular ammonium-substituted vinyl monomers, for example trialkylmethacryloxyalkylammonium, trialkylacryloxyalkylammonium,
  • Dialkyldiallylammonium and quaternary vinylammonium monomers with cyclic, cationic Nitrogen-containing groups such as pyridinium, imidazolium or quaternary pyrrolidones, for example alkylvinylimidazolium, alkylvinylpyridinium, or Alyklvinylpyrrolidon salts.
  • the alkyl groups of these monomers are preferably lower alkyl groups such as C1 to Cl alkyl groups, more preferably C1 to C3 alkyl groups.
  • the ammonium group-containing monomers may be copolymerized with non-cationic monomers.
  • Suitable comonomers are, for example, acrylamide, methacrylamide; Alkyl and dialkylacrylamide, alkyl and dialkylmethacrylamide, alkylacrylate, alkylmethacrylate, vinylcaprolactone, vinylcaprolactam, vinylpyrrolidone, vinylester, e.g. Vinyl acetate, vinyl alcohol, propylene glycol or ethylene glycol, wherein the alkyl groups of these monomers are preferably C1 to C7 alkyl groups, more preferably C1 to C3 alkyl groups.
  • Suitable polymers having quaternary amine groups are, for example, the polymers described in the CTFA Cosmetic Ingredient Dictionary under the names Polyquaternium, such as methylvinylimidazolium chloride / vinylpyrrolidone copolymer (Polyquaternium-16) or
  • quaternized vinylpyrrolidone / dimethylaminoethyl methacrylate copolymer (Polyquaternium-11).
  • cationic polymers for example vinylpyrrolidone / dimethylaminoethyl copolymer available under the trade names Gafquat ® 755 N and Gafquat ® 734, United States is marketed by Gaf Co. and of which the Gafquat ® 734 is particularly preferred suitable.
  • cationic polymers are, for example, Germany, marketed by the company BASF under the tradename Luviquat ® HM 550 copolymer of polyvinyl pyrrolidone and imidazolimine which ® by the company Calgon / USA under the trade name Merquat Plus 3300 sold terpolymer of dimethyldiallylammonium chloride, sodium acrylate and acrylamide and sold by the company ISP under the trade name Gafquat ® HS 100 vinylpyrrolidone / methacrylamidopropyltrimethylammonium chloride copolymer.
  • a particularly suitable homopolymer is the optionally crosslinked, poly (methacryloyloxyethyltrimethylammonium chloride) with the INCI name Polyquaternium 37.
  • Such products are, for example, under the names Rheocare ® CTH (Cosmetic Rheologies) and Synthalen ® CR (3V Sigma) are commercially available.
  • mineral oil (INCI name: Mineral OiI)
  • tridecyl-polyoxypropylene-polyoxyethylene ether INCI name: PPG-1-trideceth-6
  • additional components mixture of diesters of propylene glycol with a mixture of caprylic and capric acid (INCI name: propylene glycol Dicaprylate / Dicaprate) and tridecyl polyoxypropylene-polyoxyethylene-ether (INCI Designation: PPG-1-trideceth-6)) are commercially available.
  • a copolymer preferred according to the invention is the crosslinked acrylamide-methacryloyloxyethyltrimethylammonium chloride copolymer.
  • Such copolymers in which the monomers are present in a weight ratio of about 20:80, are commercially available as approximately 50% non-aqueous polymer dispersion 92 under the name Salcare ® SC.
  • Suitable cationic polymers derived from natural polymers are cationic derivatives of polysaccharides, for example, cationic derivatives of cellulose, starch or guar. Also suitable are chitosan and chitosan derivatives.
  • a cationic cellulose is sold under the name Polymer JR 400 from Amerchol ® and has the INCI designation Polyquaternium-10 degrees.
  • Another cationic cellulose bears the INCI name Polyquaternium-24 and is sold under the trade name Polymer LM-200 by Amerchol.
  • Other commercial products are the compounds Celquat ® H 100, Celquat ® L and 200. The commercial products mentioned are preferred cationic celluloses.
  • Suitable cationic guar derivatives are marketed under the trade name Jaguar ® and have the INCI name guar hydroxypropyltrimonium chloride. Further particularly suitable cationic guar derivatives are also used by the company. Hercules under the name N-Hance ® commercially. Other cationic guar derivatives are marketed by the company. Cognis under the name Cosmedia® ®. A preferred cationic guar derivative is the commercial product AquaCat® ® from. Hercules. This raw material is an already pre-dissolved cationic guar derivative.
  • a suitable chitosan is sold, for example, by Kyowa Oil & Fat, Japan under the trade name Flonac ®.
  • a preferred chitosan is chitosoniumpyrrolidone is, for example, sold under the name Kytamer ® PC by Amerchol, USA.
  • Further chitosan derivatives are Hydagen® ® CMF, Hydagen® ® HCMF and Chitolam ® NB / 101 freely available under the trade names in the trade.
  • honey for example the commercial product Honeyquat ® 50,
  • Vinylpyrrolidone vinylimidazoliummethochloride copolymers such as those offered under the names Luviquat.RTM ® FC 370, FC 550, FC 905 and HM 552,
  • Vinylpyrrolidone-Vinylcaprolactam-acrylate terpolymers such as those with acrylic acid esters and acrylamides as a third monomer building commercially, for example, under the
  • Designation Aquaflex ® SF 40 are offered.
  • Gaffix ® VC 713 manufactured by ISP:
  • the copolymers of vinylpyrrolidone such as the commercial products Copolymer 845 (ISP manufacturer) are Gafquat ® ASCP 1011, Gafquat ® HS 110, Luviquat ® 8155 and Luviquat ® MS 370 available are.
  • cationized protein hydrolysates are to be counted among the cationic polymers, wherein the underlying protein hydrolyzate from the animal, for example from collagen, milk or keratin, from the plant, for example from wheat, corn, rice, potatoes, soy or almonds, marine life forms, for example from fish collagen or algae, or biotechnologically derived protein hydrolysates.
  • the cationic protein hydrolysates and derivatives according to the invention those mentioned under the INCI names in the "International Cosmetic Ingredient Dictionary and Handbook", (seventh edition 1997, The Cosmetic, Toiletry, and Fragrance Association 1101 17 th Street, NW, Suite 300 Washington, DC 20036-4702) and commercially available products.
  • the cationic polymers are preferably contained in the compositions according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • Amphoteric polymers like the cationic polymers, are most preferred polymers.
  • Particularly preferred amphoteric polymers are copolymers of diallyl dimethyl ammonium chloride and acrylic acid. These copolymers are sold under the INCI name Polyquaternium-22, among others, with the trade name Merquat ® 280 (Nalco).
  • Very particularly preferably used according to the invention amphoteric polymers are terpolymers of diallyldimethylammonium chloride, acrylamide and acrylic acid. These copolymers are marketed ® under the INCI name Polyquaternium-39, among others, with the trade name Merquat Plus 3330 (Nalco).
  • amphoteric polymers are preferably contained in the agents according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • the anionic polymers are anionic polymers which have carboxylate and / or sulfonate groups.
  • anionic monomers from which such polymers may consist are acrylic acid, methacrylic acid, crotonic acid, maleic anhydride and 2-acrylamido-2-methylpropanesulfonic acid.
  • the acidic groups may be wholly or partly present as sodium, potassium, ammonium, mono- or triethanolammonium salt.
  • Anionic polymers which contain 2-acrylamido-2-methylpropanesulfonic acid as the sole or co-monomer can be found to be particularly effective, it being possible for all or some of the sulfonic acid group to be present as sodium, potassium, ammonium, mono- or triethanolammonium salt , More preferably, the homopolymer of 2-acrylamido-2-methylpropansulfon acid, which is commercially available, for example under the name Rheothik ® 11- 80.
  • Preferred anionic copolymers are acrylic acid-acrylamide copolymers and in particular polyacrylamide copolymers with sulfonic acid-containing monomers.
  • a particularly preferred anionic copolymer consists of 70 to 55 mol% of acrylamide and 30 to 45 mol% of 2-acrylamido-2-methylpropanesulfonic acid, wherein the sulfonic acid group wholly or partly as Sodium, potassium, ammonium, mono- or triethanolammonium salt is present.
  • This copolymer may also be crosslinked, with crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylenebisacrylamide are used.
  • crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylenebisacrylamide are used.
  • crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylenebisacrylamide are used.
  • Such a polymer is contained in the commercial product Sepigel ® 305 from SEPPIC.
  • Simulgel ® 600 as a compound with isohexadecane and polysorbate 80 Natriumacryloyldimethyltaurat copolymers have proven to be particularly effective according to the invention.
  • anionic homopolymers are uncrosslinked and crosslinked polyacrylic acids. Allyl ethers of pentaerythritol, sucrose and propylene may be preferred crosslinking agents. Such compounds are for example available under the trademark Carbopol ® commercially.
  • Copolymers of maleic anhydride and methyl vinyl ether, in particular those with crosslinks, are also dye-retaining polymers.
  • a 1, 9-decadiene crosslinked maleic acid-methyl vinyl ether copolymer is available under the name ® Stabileze QM.
  • the anionic polymers are preferably contained in the agents according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • Suitable nonionic polymers are, for example:
  • Vinylpyrrolidone / vinyl ester copolymers as sold, for example, under the trademark Luviskol ® (BASF). Luviskol ® VA 64 and Luviskol ® VA 73, each
  • Vinyl pyrrolidone / vinyl acetate copolymers are also preferred nonionic polymers.
  • Cellulose ethers such as hydroxypropyl cellulose, hydroxyethyl cellulose and hydroxypropylcellulose Methylhy- as for example under the trademark Culminal® ® and
  • Benecel ® (Aqualon) and Natrosol ® grades (Hercules) are sold.
  • Starch and its derivatives in particular starch, such as Structure XL ®
  • the nonionic polymers are preferably contained in the compositions according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • the polymers (P) are preferably present in the compositions used according to the invention in amounts of from 0.01 to 30% by weight, based on the total composition.
  • compositions according to the invention contain fatty substances (fat) as further active ingredient.
  • fatty substances (fat) are meant fatty acids, fatty alcohols, natural and synthetic waxes, which may be both in solid form and liquid in aqueous dispersion, and to understand natural and synthetic cosmetic oil components.
  • fatty acids can be used linear and / or branched, saturated and / or unsaturated fatty acids having 6 to 30 carbon atoms. Preference is given to fatty acids having 10 to 22 carbon atoms. Among these could be mentioned, for example, isostearic as the commercial products Emersol ® 871 and Emersol ® 875, and isopalmitic acids such as the commercial product Edenor ® IP 95, and all other products sold under the trade names Edenor ® (Cognis) fatty acids.
  • fatty acids are caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitoleic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linoleic and erucic acid and their technical mixtures.
  • the amount used is 0.1 - 15 wt.%, Based on the total mean.
  • the amount is preferably 0.5-10% by weight, with amounts of 1-5% by weight being particularly advantageous.
  • Fatty alcohols may be used are saturated, mono- or polyunsaturated, branched or unbranched fatty alcohols with C 6 - C 30 -, preferably C 10 - C 22 - and particularly preferably C 2 - C 22 - carbon atoms.
  • Decanols, octanols, dodecadienol, decadienol, oleyl alcohol, eruca alcohol, ricinoleic alcohol, stearyl alcohol, isostearyl alcohol, cetyl alcohol, lauryl alcohol, myristyl alcohol, arachidyl alcohol, caprylic alcohol, capric alcohol, linoleyl alcohol, linolenyl alcohol and behenyl alcohol are, for example, decanol, octanolol, dodecadienol, decadienol , as well as their Guerbet alcohols, this list should have exemplary and non-limiting character.
  • the fatty alcohols may be a mixture of different fatty alcohols.
  • Such substances are, for example, under the names Stenol ® such as Stenol ® 1618 or Lanette ® such as Lanette ® O or Lorol ®, for example, Lorol ® C8, Lorol C14 ®, Lorol C18 ®, ® Lorol C8-18, HD-Ocenol ®, Crodacol ® such as Crodacol ® CS, Novol ®, Eutanol ® G, Guerbitol ® 16, Guerbitol ® 18, Guerbitol ® 20, Isofol ® 12, Isofol ® 16, Isofol ® 24, Isofol ® 36, Isocarb ® 12, Isocarb ® 16 or acquire Isocarb® ® 24 for sale.
  • Stenol ® such as Stenol ® 1618 or Lanette ® such as Lanette ® O or Lo
  • wool wax alcohols as are commercially available, for example under the names of Corona ®, White Swan ®, Coronet ® or Fluilan ® can be used according to the invention.
  • the fatty alcohols are used in amounts of from 0.1 to 30% by weight, based on the total preparation, preferably in amounts of from 0.1 to 20% by weight.
  • waxes As natural or synthetic waxes (Fatwax), solid paraffins or isoparaffins, carnauba waxes, beeswaxes, candelilla waxes, ozokerites, ceresin, spermaceti, sunflower wax, fruit waxes such as apple wax or citrus wax, microwaxes of PE or PP can be used according to the invention.
  • Such waxes are available, for example, from Kahl & Co., Trittau.
  • the amount used is 0.1-50 wt.% Based on the total agent, preferably 0.1 to 20 wt.% And particularly preferably 0.1 to 15 wt.% Based on the total agent.
  • the total amount of oil and fat components in the compositions according to the invention is usually 0.5-75% by weight, based on the total agent. Amounts of 0.5-35 wt .-% are preferred according to the invention.
  • compositions according to the invention with the active ingredient complex according to the invention are protein hydrolysates and / or derivatives thereof (P).
  • protein hydrolysates of both vegetable and animal or marine or synthetic origin can be used.
  • Animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein protein hydrolysates, which may also be present in the form of salts.
  • Such products are, for example, under the trademarks Dehylan ® (Cognis), Promois® ® (Interorgana) Collapuron ® (Cognis), Nutrilan® ® (Cognis), Gelita-Sol ® (German Gelatinefabriken Stoess & Co), Lexein ® (Inolex) and kerasol tm ® (Croda) sold.
  • Further preferred vegetable protein hydrolysates according to the invention are, for example, soya, almond, pea, potato and wheat protein hydrolysates.
  • Such products are, for example, under the trademarks Gluadin ® (Cognis), diamine ® (Diamalt) ® (Inolex), Hydrosoy ® (Croda), hydro Lupine ® (Croda), hydro Sesame ® (Croda), Hydro tritium ® (Croda) and Crotein ® (Croda) available.
  • protein hydrolysates according to the invention are of maritime origin. These include, for example, collagen hydrolyzates of fish or algae as well as protein hydrolysates of mussels or pearl hydrolyzates.
  • pearl extracts according to the invention are the commercial products Pearl Protein Extract BG ® or Crodarom ® Pearl.
  • the protein hydrolysates (P) are present in the compositions in concentrations of 0.001% by weight to 20% by weight, preferably from 0.05% by weight to 15% by weight and most preferably in amounts of 0.05% by weight. up to 5% by weight.
  • compositions according to the invention can be further increased by a 2-pyrrolidinone-5-carboxylic acid and its derivatives (J).
  • the sodium salt is most preferred.
  • the amounts used in the inventive compositions are 0.05 to 10 wt.%, Based on the total agent, particularly preferably 0.1 to 5, and in particular 0.1 to 3 wt.%.
  • vitamins are vitamins, provitamins or vitamin precursors.
  • Vitamins, pro-vitamins and vitamin precursors are particularly preferred, which are assigned to the groups A, B, C, E, F and H.
  • vitamin A includes retinol (vitamin A 1 ) and 3,4-didehydroretinol (vitamin A 2 ).
  • the ß-carotene is the provitamin of retinol.
  • vitamin A component according to the invention for example, vitamin A acid and its esters, vitamin A aldehyde and vitamin A alcohol and its esters such as the palmitate and the acetate in Consideration.
  • the agents according to the invention preferably contain the vitamin A component in amounts of 0.05-1% by weight, based on the total preparation.
  • the vitamin B group or the vitamin B complex include u. a.
  • Vitamin B 1 (thiamine)
  • Vitamin B 2 (riboflavin)
  • Vitamin B 3 the compounds nicotinic acid and nicotinamide (niacinamide) are often performed.
  • Preferred according to the invention is the nicotinic acid amide which is contained in the agents used according to the invention preferably in amounts of from 0.05 to 1% by weight, based on the total agent.
  • Vitamin B 5 pantothenic acid, panthenol and pantolactone.
  • Panthenol and / or pantolactone are preferably used in the context of this group.
  • Derivatives of panthenol which can be used according to the invention are, in particular, the esters and ethers of panthenol and also cationically derivatized panthenols. Individual representatives are for example the
  • the said compounds of the vitamin B 5 type are in the
  • Agents according to the invention preferably in amounts of 0.05 to 10 wt .-%, based on the total agent. Amounts of 0.1-5 wt .-% are particularly preferred.
  • Vitamin B 6 pyridoxine and pyridoxamine and pyridoxal.
  • Vitamin C (ascorbic acid). Vitamin C is used in the agents according to the invention preferably in amounts of 0.1 to 3 wt .-%, based on the total agent. Use in the form of palmitic acid ester, glucosides or phosphates may be preferred. The use in combination with tocopherols may also be preferred.
  • Vitamin E tocopherols, especially ⁇ -tocopherol.
  • Tocopherol and its derivatives which include in particular the esters such as the acetate, the nicotinate, the phosphate and the succinate, are preferably present in the agents according to the invention in amounts of 0.05-1% by weight, based on the total agent.
  • Vitamin F is usually understood as meaning essential fatty acids, in particular linoleic acid, linolenic acid and arachidonic acid.
  • Vitamin H is the compound (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-d] - imidazole-4-valeric acid, for which, however, the trivial name biotin has meanwhile prevailed.
  • Biotin is preferably present in the compositions according to the invention in amounts of from 0.0001 to 1.0% by weight, in particular in amounts of from 0.001 to 0.01% by weight.
  • compositions according to the invention preferably contain vitamins, provitamins and vitamin precursors from groups A, B, E and H. Panthenol, pantolactone, pyridoxine and its derivatives as well as nicotinic acid amide and biotin are particularly preferred.
  • plant extracts (L) in the compositions according to the invention gives rise to further advantages.
  • Ayurvedic plant extracts are used as plant extracts.
  • Traditional Ayurvedic plants include Aegle Marmelos (Bilwa), Cyperus Rotundus (Nagar Motha), Emblica officinalis (Amalki), Morida Citrifolia (Ashyuka), Tinospora Cordifolia (Guduchi), Santalum album, (Chandana), Crocus sativus (Kumkuma), Cinnamonum Zeylanicum and Nelumbo Nucifera (Kamala).
  • the agents according to the invention may contain purine and / or derivative (s) of purine.
  • Preferred compositions of the invention contain purine and / or purine derivatives in narrower ranges.
  • preferred cosmetic compositions according to the invention are characterized in that they contain, based on their weight, from 0.001 to 2.5% by weight, preferably from 0.0025 to 1% by weight, particularly preferably from 0.005 to 0.5% by weight and in particular from 0.01 to 0.1% by weight of purine (s) and / or purine derivative (s).
  • purine the purines and the purine derivatives
  • the following compounds are preferred according to the invention: purine, adenine, guanine, uric acid, hypoxanthine, 6-purinethiol, 6-thioguanine, xanthine, caffeine, theobromine and theophylline.
  • purine adenine, guanine, uric acid, hypoxanthine, 6-purinethiol, 6-thioguanine, xanthine, caffeine, theobromine and theophylline.
  • caffeine proven useful, for example, in shampoos, conditioners, hair lotions and / or lotions preferably in amounts of 0.005 to 0.25 wt .-%, more preferably from 0.01 to 0.1 wt .-% and in particular of 0.01 to 0.05 wt .-% (in each case based on the composition) can be used.
  • taurine is understood to mean exclusively 2-aminoethanesulfonic acid and explicitly mentioned derivatives of taurine.
  • Taurine derivatives are understood as meaning N-monomethyltaurine and N, N-dimethyltaurine.
  • Other taurine derivatives also include taurines, which naturally occur as metabolites in plant and / or animal and / or marine organisms. These include, for example, although not preferred, degradation products of cysteine, especially cysteine sulfinic acid.
  • Further taurine derivatives for the purposes of the present invention are taurocholic acid and hypotaurine.
  • agents according to the invention which - based on their weight - 0.0001 to 10.0 wt .-%, preferably 0.0005 to 5.0 wt .-%, particularly preferably 0.001 to 2.0 wt .-% and In particular, 0.001 to 1, 0 wt .-% taurine and / or a derivative of taurine included.
  • the compositions according to the invention may prove advantageous if the compositions according to the invention contain penetration aids and / or swelling agents (M).
  • urea and urea derivatives include, for example, urea and urea derivatives, guanidine and its derivatives, arginine and its derivatives, water glass, imidazole and its derivatives, histidine and its derivatives, benzyl alcohol, glycerol, glycol and glycol ethers, propylene glycol and propylene glycol ethers, for example propylene glycol monoethyl ether, carbonates, bicarbonates, Diols and triols, and in particular 1, 2-diols and 1, 3-diols such as 1, 2-propanediol, 1, 2-pentanediol, 1, 2-hexanediol, 1, 2-dodecanediol, 1, 3-propanediol, 1 , 6-hexanediol, 1, 5-pentanediol, 1, 4-butanediol.
  • a particularly preferred group of swelling agents may be hydantoins.
  • invention Compositions preferably contain 0.01 to 5 wt .-% hydantoin or at least one Hydatoinderivates.
  • Hydantoin derivatives are particularly preferably used according to the invention, with 5-ureidohydantoin being particularly preferred.
  • amounts of from 0.02 to 2.5 wt .-% are very particularly preferred, from 0.05 to 1, 5 wt .-%, more preferably 0.075 to 1 wt .-% and in particular 0.1 to 0.25 wt .-% - each based on the total agent - most preferably.
  • the use according to the invention of polyhydroxy compounds as active ingredient with the other components according to the invention may be particularly preferred.
  • Polyhydroxy compounds are understood as meaning organic compounds having at least two hydroxyl groups. In particular, for the purposes of the present invention, this is to be understood as meaning:
  • Polyols having at least two hydroxyl groups such as, for example, trimethylolpropane, carbohydrates, sugar alcohols and sugars, and salts thereof,
  • monosaccharides in particular monosaccharides, disaccharides, trisaccharides and oligosaccharides, which may also be in the form of aldoses, ketoses and / or lactoses,
  • monosaccharides having 3 to 8 C atoms such as, for example, trioses, tetroses, pentoses, hexoses, heptoses and octoses, these also being able to be present in the form of aldoses, ketoses and / or lactoses.
  • oligosaccharides having up to 50 monomer units.
  • the polyols according to the invention include sorbitol, inositol, mannitol, tetrite, pentite, hexite, threitol, erythritol, adonite, arabitol, xylitol, dulcitol, erythrose, threose, arabinose, ribose, xylose, lyxose, glucose, galactose, mannose, allose , Altrose, gulose, idose, talose, fructose, sorbose, psicose, tegatose, deoxyribose, glucosamine, galactosamine, rhamnose, digitoxose, thioglucose, sucrose, lactose, trehalose, maltose, cello
  • Preferred polyhydroxy compounds are sorbitol, inositol, mannitol, threitol, erythrose, erythrose, threose, arabinose, ribose, xylose, glucose, galactose, mannose, allose, fructose, sorbose, deoxyribose, glucosamine, galactosamine, sucrose, lactose, trehalose, maltose and cellobiose , Particular preference is given to using glucose, galactose, mannose, fructose, deoxyribose, glucosamine, sucrose, lactose, maltose and cellobiose. However, the use of glucose, galactose, mannose, fructose, sucrose, lactose, maltose or cellobiose is very particularly preferred
  • glycerin is of outstanding importance.
  • agents according to the invention which, based on the weight of the composition, contain 0.01 to 5 wt.%, Preferably 0.05 to 4 wt.%, Particularly preferably 0.05 to 3.5% by weight and in particular 0.1 to 2.5% by weight of polyhydroxy compound (s).
  • Very particularly preferred polyols of the present invention are polyols having 2 to 12 C atoms in the molecular skeleton. These polyols can be straight-chain, branched, cyclic and / or be unsaturated.
  • the hydroxyl groups are very particularly preferably terminally adjacent or terminally separated from one another by the remainder of the chain.
  • polystyrene resin examples include polyethylene glycol up to a molecular weight of up to 1000 daltons, neopentyl glycol, partial glycerol ethers having a molecular weight of up to 1000 daltons, 1,2-propanediol, 1,3-propanediol, glycerol, 1,2-butanediol , 1, 3-butanediol, 1, 4-butanediol, 1, 2,3-butanetriol, 1, 2,4-butanetriol, pentanediols, for example 1, 2-pentanediol, 1, 5-pentanediol, hexanediols, 1, 2- Hexanediol, 1,6-hexanediol, 1, 2,6-hexanetriol, 1,4-cyclohexanediol, 1,2-cyclohexanediol, heptanedio
  • the polyhydroxy compounds according to the invention are present in the compositions in concentrations of 0.01% by weight up to 20% by weight, preferably from 0.05% by weight up to 15% by weight and very particularly preferably in amounts of 0.1% by weight. up to 10% by weight.
  • the agents according to the invention should additionally contain at least one UV light protection filter.
  • UV light protection filters are meant organic substances capable of absorbing ultraviolet rays and absorbing the absorbed energy in the form of longer wavelength radiation, e.g. Heat again. UVB filters can be oil-soluble or water-soluble.
  • the cosmetic agents may contain other active ingredients, auxiliaries and additives, such as
  • Structurants such as maleic acid and lactic acid
  • Anti-dandruff agents such as Piroctone Olamine, Zinc Omadine and Climbazole,
  • Opacifiers such as latex, styrene / PVP and styrene / acrylamide copolymers
  • Pearlescing agents such as ethylene glycol mono- and distearate and PEG-3-distearate,
  • Propellants such as propane-butane mixtures, N 2 O, dimethyl ether, CO 2 and air,
  • the high care effect of the agents according to the invention is of particular importance, in particular, since it gives excellent results even in the presence of oxidizing agents, for example in the context of oxidative hair dyeing.
  • a second subject of the invention is therefore a method for hair treatment, in which a cosmetic composition according to claim 1 is applied to the hair and rinsed after a contact time of the hair.
  • the exposure time is preferably a few seconds to 100 minutes, more preferably 1 to 50 minutes and most preferably 1 to 30 minutes.
  • a third subject of the invention is a method of hair treatment in which a cosmetic
  • Agent according to claim 1 is applied to the hair and on the hair until the next
  • a fourth subject of the invention is that the cosmetic composition as a non-aerosol
  • Spray is present and applied to the hair and remains there until the next hair wash.
  • Non aerosol spray conditioner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

L'invention concerne des produits de traitement capillaire monophasiques renfermant un copolymère cationique et présentant une teneur accrue en silicones ainsi que l'utilisation de ces produits pour le traitement des cheveux.
PCT/EP2010/058442 2009-07-02 2010-06-16 Soin capillaire monophasique à teneur accrue en silicone Ceased WO2011000698A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102009027427.8 2009-07-02
DE200910027427 DE102009027427A1 (de) 2009-07-02 2009-07-02 Einphasige Haarkur mit erhöhtem Anteil an Silikon

Publications (2)

Publication Number Publication Date
WO2011000698A2 true WO2011000698A2 (fr) 2011-01-06
WO2011000698A3 WO2011000698A3 (fr) 2011-06-16

Family

ID=43298876

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2010/058442 Ceased WO2011000698A2 (fr) 2009-07-02 2010-06-16 Soin capillaire monophasique à teneur accrue en silicone

Country Status (2)

Country Link
DE (1) DE102009027427A1 (fr)
WO (1) WO2011000698A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013079212A (ja) * 2011-10-04 2013-05-02 Arimino Kagaku Kk 毛髪化粧料
WO2013072171A3 (fr) * 2011-11-17 2014-07-24 Henkel Ag & Co. Kgaa Produit de traitement et de soins capillaires

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6235275B1 (en) * 1999-06-25 2001-05-22 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Water-in-oil hair conditioner with lamellar dispersion in water phase
CN101203206A (zh) * 2005-06-21 2008-06-18 宝洁公司 包含凝胶基质和高分子量水溶性阳离子聚合物的毛发调理组合物
EP1927335B1 (fr) * 2006-11-24 2009-10-21 KPSS-Kao Professional Salon Services GmbH Composition à deux phases pour le conditionnement
MX2010010726A (es) * 2008-03-28 2010-10-25 Unilever Nv Composicion de estilizado de cabello.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
""International Cosmetic Ingredient Dictionary and Handbook", (seventh edition )", 1997, TOILETRY, AND FRAGRANCE ASSOCIATION

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013079212A (ja) * 2011-10-04 2013-05-02 Arimino Kagaku Kk 毛髪化粧料
WO2013072171A3 (fr) * 2011-11-17 2014-07-24 Henkel Ag & Co. Kgaa Produit de traitement et de soins capillaires

Also Published As

Publication number Publication date
DE102009027427A1 (de) 2011-01-05
WO2011000698A3 (fr) 2011-06-16

Similar Documents

Publication Publication Date Title
EP2593189A2 (fr) Compositions de conditionnement capillaire
EP2528582A2 (fr) Produits de conditionnement capillaire contenant des silicones cationiques et de la diméthicone
WO2010018047A2 (fr) Composition cosmétique contenant des huiles issues des fruits du sumac
WO2011113501A1 (fr) Produits de soins capillaires contenant au moins quatre huiles sélectionnées
EP2349195A2 (fr) Agents de conditionnement capillaire contenant des imidazolines
EP2654701B1 (fr) Agents de traitement capillaire monophase ayant une teneur augmentée en silicone
EP2347795A2 (fr) Conditionnement de fibres kératiniques à longue tenue
WO2011009710A2 (fr) Produits de conditionnement capillaire contenant des imidazolines cationiques et des silicones cationiques sélectionnées
DE102009044948A1 (de) Mittel zur Behandlung keratinischer Fasern enthaltend Dimethylsilanol Hyaluronate und Glycerin
EP2317972A2 (fr) Agents de conditionnement capillaire contenant des imidazolines
EP2340011A2 (fr) Agents de conditionnement capillaire contenant des imidazolines
EP2464329A2 (fr) Compositions pour soins capillaires contenant de l huile de ramboutan
EP2705878A2 (fr) Cure capillaire à l'aide d'huiles d'esters sélectionnées, de silicones sélectionnés et de dérivés d'acide acrylique sélectionnés avec une faible teneur en eau
WO2010000632A2 (fr) Agents de conditionnement capillaire contenant des imidazolines
WO2011000698A2 (fr) Soin capillaire monophasique à teneur accrue en silicone
WO2010000582A2 (fr) Agents de conditionnement capillaire contenant des imidazolines
EP2340012A2 (fr) Agents de conditionnement capillaire contenant des imidazolines
EP2335672A2 (fr) Soin capillaire sans silicone
WO2011020646A2 (fr) Compositions de soin capillaire contenant de l'alcool lanolique à teneur élevée en alcools gras à longue chaîne
DE102009028537A1 (de) Zusammensetzungen zur Haarpflege enthaltend natürliche Öle mit hohen Anteilen gesättigter Fettsäuren
WO2010000658A2 (fr) Agents de conditionnement capillaire contenant des imidazolines
DE102009045997A1 (de) Haarbehandlungsmittel mit Polyquaternium-72
DE102009027865A1 (de) Haarbehandlungsmittel mit einem Extrakt aus Crithmum maritimum
DE102009029196A1 (de) Haarbehandlungsmittel mit einem Campanulata Flower Extrakt
EP2456420A2 (fr) Produits de conditionnement capillaire contenant des silicones cationiques sélectionnées et une vitamine de la série b

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10725679

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10725679

Country of ref document: EP

Kind code of ref document: A2